Literature DB >> 9709382

Uses and abuses of enzyme therapy in cystic fibrosis.

P Durie1, D Kalnins, L Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9709382      PMCID： PMC1296367          DOI： 10.1177/014107689809134s02

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  56 in total

1.  Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.

Authors:  D Y Graham
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

2.  Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.

Authors:  E P DiMagno; J R Malagelada; V L Go; C G Moertel
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

3.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.

Authors:  F B Stapleton; J Kennedy; S Nousia-Arvanitakis; M A Linshaw
Journal:  N Engl J Med       Date:  1976-07-29       Impact factor: 91.245

5.  Iatrogenic hyperuricemia in children with cystic fibrosis.

Authors:  G P Davidson; F M Hassel; D Crozier; M Corey; G G Forstner
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

6.  Titrimetric measurements of fecal trypsin and chymotrypsin in cystic fibrosis with pancreatic exocrine insufficiency.

Authors:  W P Dyck
Journal:  Am J Dig Dis       Date:  1967-03

7.  The effect of cimetidine on maldigestion in cystic fibrosis.

Authors:  K L Cox; J N Isenberg; A B Osher; R R Dooley
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

8.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

9.  Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.

Authors:  B J Boyle; W B Long; W F Balistreri; S J Widzer; N Huang
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

10.  Hypersensitivity to pancreatic extracts in parents of patients with cystic fibrosis.

Authors:  F J Twarog; S F Weinstein; K T Khaw; D J Strieder; H R Colten
Journal:  J Allergy Clin Immunol       Date:  1977-01       Impact factor: 10.793
View more
  5 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.

Authors:  Maisam Abu-El-Haija; Marek Sinkora; David K Meyerholz; Michael J Welsh; Paul B McCray; John Butler; Aliye Uc
Journal:  Pancreatology       Date:  2011-11-01       Impact factor: 3.996

3.  Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.

Authors:  Michael W Konstan; Drucy Borowitz; Nicole Mayer-Hamblett; Carlos Milla; Leslie Hendeles; Susan Murray; Richard A Kronmal; Susan Casey; Lynn M Rose; Wayne J Morgan; Bonnie W Ramsey
Journal:  Clin Investig (Lond)       Date:  2013-08

Review 4.  Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies.

Authors:  Daina Kalnins; Michael Wilschanski
Journal:  Drug Des Devel Ther       Date:  2012-06-20       Impact factor: 4.162

5.  Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard?

Authors:  Drucy Borowitz; Nell Aronoff; Linda C Cummings; Asim Maqbool; Andrew E Mulberg
Journal:  Pancreas       Date:  2022-06-11       Impact factor: 3.243
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.